• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
Search 
  •   COVID-19
  • Resources in English
  • Search
  •   COVID-19
  • Resources in English
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 11-20 of 384

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
  • Thumbnail

    Impacts of remdesivir on dynamics and efficacy stratified by the severity of COVID- 19: a simulated two-arm controlled study 

    Lin, Ting-Yu et al. (2020-05-22)
    Background: The impact of remdesivir on length of stay of hospitalization, high-risk state, and death stratified by the severity of COVID-19 at enrollment is controversial. Methods: We applied a simulated two-arm controlled ...
  • Thumbnail

    SARS-CoV-2 seroconversion in health care workers 

    Shields, Adrian M et al. (2020-05-19)
    Background The correlates of protection against SARS-CoV-2 and their longevity remain unclear. Studies in severely ill individuals have identified robust cellular and humoral immune responses against the virus. Asymptomatic ...
  • Thumbnail

    Hydroxychloroquine in COVID-19: A systematic review and meta-analysis 

    Chacko, Jose; Brar, Gagan; Premkumar, Robert (2020-05-20)
    Abstract Background Hydroxychloroquine is being administered among patients with COVID19 infection in many healthcare systems across the world considering its in vitro effect against the SARS CoV 2 virus. In spite of several ...
  • Thumbnail

    Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France 

    Fafi-Kremer, Samira et al. (2020-05-22)
    Background: The serologic response of individuals with mild forms of SARS-CoV-2 infection is poorly characterized. Methods: Hospital staff who had recovered from mild forms of PCR-confirmed SARS-CoV-2 infection were tested ...
  • Thumbnail

    Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy 

    Macias, Juan et al. (2020-05-20)
    Background: Hydroxychloroquine is currently being tested as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19) in several ongoing clinical trials. Objective: To compare the incidence of COVID-19 in Spanish ...
  • Thumbnail

    Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea 

    Kim, Min Seo et al. (2020-06-14)
    The authors have withdrawn this manuscript because of the controversy about hydroxychloroquine and potential changes in results after peer-review, the authors intend to share their results in formal publication. Therefore, ...
  • Thumbnail

    Susceptibility to and transmission of COVID-19 amongst children and adolescents compared with adults: a systematic review and meta-analysis 

    Viner, Russell M et al. (2020-05-24)
    Background The degree to which children and young people are infected by and transmit the SARS-CoV-2 virus is unclear. Clinical series and testing cohorts based upon screening of symptomatic cases provide biased estimates ...
  • Thumbnail

    High seroreactivity against SARS-CoV-2 Spike epitopes in a pre SARS-CoV-2 cohort: implications for antibody testing and vaccine design 

    Palm, Kaia et al. (2020-05-22)
    Little is known about the quality of polyclonal antibody responses in COVID-19 patients, and how it correlates with disease severity or patients' prior exposure to other pathogens. The whole polyclonal antibody repertoire ...
  • Thumbnail

    Improved measurement of racial/ethnic disparities in COVID-19 mortality in the United States 

    Goldstein, Joshua Robert; Atherwood, Serge (2020-05-23)
    Different estimation methods produce diverging accounts of racial/ethnic disparities in COVID-19 mortality in the United States. The Center for Disease Control's decision to present the racial/ethnic distribution of COVID-19 ...
  • Thumbnail

    Underreporting of death by COVID-19 in Brazil's second most 

    Alves, Thiago Henrique Evangelista et al. (2020-05-23)
    The COVID-19 pandemic brings to light the reality of the Brazilian health system. The underreporting of COVID-19 deaths in the state of Minas Gerais (MG), where is concentrated the second largest population of the country, ...
  • 1
  • 2
  • 3
  • 4
  • 5
  • . . .
  • 39

Discover

CategoryClinical characterization and management (120)Infection prevention and control, including health care workers protection (81)Virus: natural history, transmission and diagnostics (72)Candidate therapeutics RD (66)Epidemiology and epidemiological studies (65)Public Health Interventions (42)Health systems and services (24)Ethical considerations for research (19)Social sciences in the response (14)Prehospital Emergency Medical Services (6)... View MoreLanguageEnglish (379)Español (1)Other (1)Português (1)TypePublished Article (354)Other publications (18)Research protocol information (9)Other public health institution guidance (2)WHO / PAHO Guidance (1)CountryOthers (291)Global (WHO/OMS) (89)Brasil (1)Canada (1)Chile (1)United States (1)AuthorEvidence Aid (9)BMJ Best Practice (4)European Centre for Disease Prevention and Control (4)Chen, Guang et al. (2)Kim, Min Seo et al. (2)Kurniawan, Andree (2)McMaster Health Forum (2)National Collaborating Centre for Methods and Tools (2)National Institute for Health and Care Excellence (2)Pan American Health Organization (2)... View MoreSubject
Coronavirus Infections (384)
COVID-19 (378)Coronavirus (285)Infectious Diseases (230)Betacoronavirus (150)SARS-CoV-2 (123)Systematic Review (60)Pandemics (44)Mortality (34)Meta-Analysis (31)... View MoreDate Issued2020 (376)2021 (5)2015 (2)2019 (1)

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjectsThis CommunityBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)